Somnambulism (Sleep Walking) Medication

  • Author: Gregory Ackroyd, MD; Chief Editor: Selim R Benbadis, MD   more...
 
Updated: Mar 25, 2010
 

Medication Summary

The goal of pharmacotherapy is to reduce morbidity and to prevent complications. In addition to the agents listed below, up to 6 mg Melatonin may be used at bedtime.

Next

Tricyclic antidepressants

Class Summary

These agents, comprising a complex group of drugs, have central and peripheral anticholinergic effects and sedative effects. They block the active reuptake of norepinephrine and serotonin.

Amitriptyline (Elavil)

 

Increases synaptic concentration of serotonin and/or norepinephrine in CNS by inhibiting reuptake at presynaptic neuronal membrane. Useful as analgesic for certain types of chronic and neuropathic pain.

Nortriptyline (Aventyl HCl, Pamelor)

 

Has demonstrated effectiveness in treatment of chronic pain. Increases synaptic concentration of serotonin and/or norepinephrine in CNS by inhibiting their reuptake by presynaptic neuronal membrane. Additional pharmacodynamic effects such as desensitization of adenyl cyclase and downregulation of beta-adrenergic receptors and serotonin receptors appear to play role.

Previous
Next

Benzodiazepines

Class Summary

A large group of compounds with a benzene ring nucleus fused to a 7-sided diazepine ring. Benzodiazepines bind to specific receptors in association with GABA-binding sites on chloride channels. The frequency of channel opening is increased, increasing flow of chloride ions into neurons. Their relatively high therapeutic index and lower abuse potential than many of other sedative-hypnotics have made them sedative-hypnotic drugs of choice.

Clonazepam (Klonopin)

 

Believed to enhance activity of inhibitory neurotransmitter GABA in CNS. Antiseizure and antipanic effectiveness has been demonstrated. Generally considered DOC for disorders of arousal.

Previous
Proceed to Follow-up
 
 
Contributor Information and Disclosures
Author

Gregory Ackroyd, MD  Consulting Staff, North Bay Sleep Medicine Institute

Gregory Ackroyd, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, and American Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

O'Neill F D'Cruz, MD  Professor, Departments of Neurology and Pediatrics, Director, Pediatric Sleep Program, University of North Carolina

O'Neill F D'Cruz, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Medical Association, Child Neurology Society, and North Carolina Medical Society

Disclosure: Nothing to disclose.

Stephen J Sharp, MD  Assistant Professor of Neurology and Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland

Stephen J Sharp, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Pediatrics, and Child Neurology Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Anthony M Murro, MD  Laboratory Director, Professor, Department of Neurology, Medical College of Georgia

Anthony M Murro, MD is a member of the following medical societies: American Academy of Neurology and American Epilepsy Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Senior Pharmacy Editor, eMedicine

Disclosure: eMedicine Salary Employment

Kenneth J Mack, MD, PhD  Senior Associate Consultant, Department of Child and Adolescent Neurology, Mayo Clinic

Kenneth J Mack, MD, PhD is a member of the following medical societies: American Academy of Neurology, Child Neurology Society, Phi Beta Kappa, and Society for Neuroscience

Disclosure: Nothing to disclose.

Chief Editor

Selim R Benbadis, MD  Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital

Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association

Disclosure: UCB Pharma Honoraria Speaking, consulting; Lundbeck Honoraria Speaking, consulting; Cyberonics Honoraria Speaking, consulting; Glaxo Smith Kline Honoraria Speaking, consulting; Ortho McNeil Honoraria Speaking, consulting; Pfizer Honoraria Speaking, consulting; Sleepmed/DigiTrace Speaking, consulting

References
  1. Hoque R, Chesson AL Jr. Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. J Clin Sleep Med. Oct 15 2009;5(5):471-6. [Medline].

  2. Sattar SP, Ramaswamy S, Bhatia SC, Petty F. Somnambulism due to probable interaction of valproic acid and zolpidem. Ann Pharmacother. Oct 2003;37(10):1429-33. [Medline].

  3. Oulis P, Kokras N, Papadimitriou GN, Masdrakis VG. Bupropion-induced sleepwalking. J Clin Psychopharmacol. Feb 2010;30(1):83-4. [Medline].

  4. Owens J, Opipari L, Nobile C, Spirito A. Sleep and daytime behavior in children with obstructive sleep apnea and behavioral sleep disorders. Pediatrics. Nov 1998;102(5):1178-84. [Medline].

  5. Dahl RE, Puig-Antich J. Sleep disturbances in child and adolescent psychiatric disorders. Pediatrician. 1990;17(1):32-7. [Medline].

  6. Ajlouni KM, Ahmad AT, El-Zaheri MM, et al. Sleepwalking associated with hyperthyroidism. Endocr Pract. Jan-Feb 2005;11(1):5-10. [Medline].

  7. Guilleminault C, Kirisoglu C, da Rosa AC, et al. Sleepwalking, a disorder of NREM sleep instability. Sleep Med. Mar 2006;7(2):163-70. [Medline].

  8. Guilleminault C, Lee JH, Chan A, et al. Non-REM-sleep instability in recurrent sleepwalking in pre-pubertal children. Sleep Med. Nov 2005;6(6):515-21. [Medline].

  9. Hublin C, Kaprio J, Partinen M, et al. Prevalence and genetics of sleepwalking: a population-based twin study. Neurology. Jan 1997;48(1):177-81. [Medline].

  10. Klackenberg G. Somnambulism in childhood--prevalence, course and behavioral correlations. A prospective longitudinal study (6-16 years). Acta Paediatr Scand. May 1982;71(3):495-9. [Medline].

  11. Lu ML, Shen WW. Sleep-related eating disorder induced by risperidone. J Clin Psychiatry. Feb 2004;65(2):273-4. [Medline].

  12. Mahowald MW, Rosen GM. Parasomnias in children. Pediatrician. 1990;17(1):21-31. [Medline].

  13. Mahowald MW, Schenck CH. NREM sleep parasomnias. Neurol Clin. Nov 1996;14(4):675-96. [Medline].

  14. Plazzi G, Vetrugno R, Provini F, Montaqna P. Sleepwalking and other ambulatory behaviours during sleep. Neurol Sci. Dec 2005;26 Suppl 3:s193-8. [Medline].

  15. Rosen GM, Mahowald MW, Ferber R. Sleepwalking, confusional arousals, and sleep terrors in the child. In: Principles and Practice of Sleep Medicine in the Child. 1995:99-106.

  16. Stores G. Practitioner review: assessment and treatment of sleep disorders in children and adolescents. J Child Psychol Psychiatry. Nov 1996;37(8):907-25. [Medline].

  17. Wise MS. Parasomnias in children. Pediatr Ann. Jul 1997;26(7):427-33. [Medline].

  18. Zucconi M, Oldani A, Ferini-Strambi L, et al. Nocturnal paroxysmal arousals with motor behaviors during sleep: frontal lobe epilepsy or parasomnia?. J Clin Neurophysiol. Nov 1997;14(6):513-22. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.